Benefit from adjuvant tamoxifen therapy in primary breast cancer patients according oestrogen receptor, progesterone receptor, EGF receptor and HER2 status

Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

Bernard Fisher, Joseph P. Costantino, D. Lawrence Wickerham et al. · JNCI Journal of the National Cancer Institute · 1998 · 5.5K citations · Full text

Medicine, Oncology, Preventive Medicine +15

Tamoxifen for early breast cancer: an overview of the randomised trials

The Lancet · 1998 · 4.1K citations

Medicine, Endocrinology, Oncology +9

Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer

Jennet Harvey, Gary M. Clark, C. Kent Osborne et al. · Journal of Clinical Oncology · 1999 · 2.1K citations

Medicine, Endocrinology, Oncology +17

Meeting Highlights: International Expert Consensus on the Primary Therapy of Early Breast Cancer 2005

Aron Goldhirsch, John H. Glick, Richard D. Gelber et al. · Annals of Oncology · 2005 · 1.1K citations · Full text

Medicine, Oncology, Breast Oncology +3

Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor.

Kathryn B. Horwitz, William McGuire · Journal of Biological Chemistry · 1978 · 801 citations · Full text

Life Sciences, Biochemistry, Endocrinology +17